LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS GuidanceContributed by: Business WireLogoTagsMedical DevicesHealthHospitalsNeurologyHealth TechnologyCardiologyLivaNova PLC